← Back to Search

Mindfulness-Based Intervention for Schizophrenia

N/A
Waitlist Available
Led By Neil A Rector, PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at three time points (weeks 0,3, and 5) over 5 week intervention period.
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a shorter, online mindfulness therapy for people with depression, anxiety, and stress who struggle to access traditional mental health care. The therapy helps by teaching stress management and positive engagement techniques.

Eligible Conditions
  • Schizophrenia
  • Depression
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at three time points (weeks 0,3, and 5) over 5 week intervention period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at three time points (weeks 0,3, and 5) over 5 week intervention period. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Depression, Anxiety, Stress Scale-21 (DASS-21)
Generalized Anxiety Disorder - 7 (GAD-7)
Patient Health Questionnaire - 9 (PHQ-9)
Secondary study objectives
Mindfulness
Personality inventories
Perceived Stress Scale (PSS)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-based interventionExperimental Treatment1 Intervention
Participants will take part in an adapted and abbreviated version of the traditional eight-week MBCT protocol, conducted virtually via Zoom. Participants will meet for five, weekly, two-hour sessions. The group size will be larger than traditional MBCT groups (i.e. 16-20 participants rather than 12 participants).
Group II: WaitlistActive Control1 Intervention
Participants will be placed in a group with no treatment interventions for the duration of five weeks. Once these five weeks are complete, these participants will be placed in the next mindfulness clinic session to receive treatment. This does not the typical wait-list time for clinical services, which currently exceeds eight weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Intervention
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
674 Previous Clinical Trials
1,565,811 Total Patients Enrolled
Neil A Rector, PhDPrincipal InvestigatorSunnybrook Health Sciences Centre
1 Previous Clinical Trials
420 Total Patients Enrolled
~20 spots leftby Nov 2025